News

Two New Molecules Show Early Promise in Treating Alzheimer’s

Molecules blocking a receptor found in the brain called 5-HT6R could potentially be used to treat Alzheimer’s disease, according to two studies led by researchers at Moscow Institute of Physics and Technology (MIPT), according to a news release. The first study “AVN-211, Novel and Highly Selective 5-HT6 Receptor Small…

Genervon Shares Alzheimer’s Gene List Linked to Its GM6 Treatment

Genervon Biopharmaceuticals recently shared a previously confidential list of 84 genes linked to Alzheimer’s disease which are modulated by their investigational treatment GM6. The move to make the list public was based on a wish to encourage more neurological scientists to investigate broader, multi-target approaches to treat diseases…